Bizarre Patents
An electrified table cloth for preventing crawling insects from gaining access to the consumer's food or drink.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7407962 | Heteroaryl compounds useful as inhibitors or protein kinases The present invention provides compounds that are inhibitors of protein kinase, particularly inhibitors of ERK2, GSK3, PKA, CDK2 protein kinases, mammalian protein kinases involved in proliferative and neurodegenerative disorders. The invention also provides pharmac... | 08/05/2008 |
| 7345047 | Substituted [1,2,3]triazolo[4,5-d]pyrimidines The invention provides novel substituted cyclopentane compounds (in particular, substituted [1,2,3]triazolo[4,5-d]pyrimidines), their use as medicaments (in particular, their use as anti-thrombotic agents), compositions containing them and processes for their prepar... | 03/18/2008 |
| 7339058 | Process for the preparation of -([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides The N-arylsulfilimine-catalyzed coupling of aromatic sulfonyl chlorides with N-([1,2,4]triazolopyrimidin-2-yl)amines to form N-([1,2,4]triazolo-pyrimidin-2-yl)aryl sulfonamides is improved by the selection of 3-picoline or 3,5-lutidine as the base. ... | 03/04/2008 |
| 7265124 | Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound The invention provides new forms of a chemical compound of formula (I). The invention relates to forms of a chemical compound (I), in particular to crystalline and amorphous forms, more particularly four crystalline forms and an amorphous form. The invention further... | 09/04/2007 |
| 7250419 | Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. ... | 07/31/2007 |
| 7211668 | PNA monomer and precursor This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: | 05/01/2007 |
| 7141575 | Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists The use of a compound of formula (I): wherein R1 is selected from H, alkyl, aryl, alkoxy, aryloxy, alkylthio, arylthio, halogen, CN, NR5R6, NR4CONR5, NR4CONR5R6,NR4CO | 11/28/2006 |
| 7129244 | Triazolopyrimidines and related analogs as HSP90-inhibitors A compound represented by Formula I, or a polymorph, ester, tautomer, enantiomer, diastereomer, pharmaceutically acceptable salt or prodrug thereof, Wherein R1 is halogen, —OR11, —SR | 10/31/2006 |
| 7115739 | Triazole compounds useful as protein kinase inhibitors This invention describes novel triazole compounds of formula IX: wherein Z1 is nitrogen or CR9 and Z2 is nitrogen or CH, provided that at least one of Z1 and Z2 | 10/03/2006 |
| 7074929 | Certain alkylene diamine-substituted heterocycles This invention relates to novel compounds, compositions, and methods for the treatment of physiological disorders associated with an excess of neuropeptide Y. The novel compounds encompassed by the present invention are those of the formula II, IV, V, VII–IX and X... | 07/11/2006 |
| 7071192 | Respiratory syncytial virus replication inhibitors The present invention concerns compounds of formula (I), prodrugs, N-oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms thereof wherein -a1=a2-a3=a4-represents a radical of formu... | 07/04/2006 |
| 7067663 | Triazolo pyrimidine compounds Pyrimidine compound (I) useful as a pharmaceutical intermediate, a process for preparing the pyrimidine compound (I), to intermediates used in the process, and use of the pyrimidine compo... | 06/27/2006 |
| 7034032 | Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds The invention provides novel 1,2,3-triazolo[4,5-d]pyrimidine compounds, such as those represented by formula (I): their use as medicaments, particularly in platelet aggregation disorders, compositions containi... | 04/25/2006 |
| 7015222 | Agricultural compositions An agricultural composition comprising the chemical formula, or salt thereof, of: wherein Rx is —NH2, —OH, halogen, akylamino, SR1, carboxyalkyl, carboxy, or a sulfonam... | 03/21/2006 |
| 6974868 | Compounds The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. ... | 12/13/2005 |
| 6919453 | Colorant compositions Colorant compositions, and intermediate chemical compositions of colorant compositions are made from 1,2,4-triazolo[4,3-a][1,3,5]triazine-3,5,7-substituted compounds. ... | 07/19/2005 |
| 6858616 | Nitrogen containing heterobicycles as factor Xa inhibitors The present application describes nitrogen containing heterobicyclics and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa. ... | 02/22/2005 |
| 6844348 | 2,3,4-cyclopentan-2,3,4-triol-1-yl compounds The invention provides a compound of formula (I): wherein R1 is alkyl C1-6 or alkenyl C2-6, both independently optionally substituted by one or more groups selected from alkyl C1-5... | 01/18/2005 |
| 6790841 | 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents Compounds which are active against viruses have the following Formulas: wherein B is a purine or pyrimidine heterocyclic ring and is preferably selected from the group consisting of 6-aminopurine (adenine), 2,6-diaminopu... | 09/14/2004 |
| 6767910 | Triazolo[4,5-d]pyrimidinyl compounds Compounds of the formula (I) and their use as anti-platelet aggregation compounds. ... | 07/27/2004 |
| 6734180 | NF-κB inhibitor comprising an indan derivative as an active ingredient An inhibitor of NF-κB comprising as an active ingredient an indan derivative represented by the general formula (I) or a salt thereof. ... | 05/11/2004 |
| 6713483 | [1,2,3]-triazolo[4,5-d] pyrimidine compounds The invention provides [1,2,3]-triazolo[4,5-d]pyrimidine analogue compounds of formula (I) The invention is also directed to pharmaceutical compositions containing the compounds, processes for the preparation of the comp... | 03/30/2004 |
| 6645965 | Nitrate salts of antihypertensive medicines Nitric acid salts with medicines having an antihypertensive activity.... | 11/11/2003 |
| 6635647 | Decahydro-isoquinolines The invention provides compounds of formula (I) ##STR1## wherein A, B and R are as defined herein and the preparation thereof. The compounds of formula (I) are useful as somatostatin antagonists.... | 10/21/2003 |
| 6600038 | Carbamoyl tetrahydropyridine derivatives Carbamoyl tetrahydropyridine derivatives represented by the formula: ##STR1## [in the formula, R1 and R2 are identical or different, and each represents a hydrogen atom, a C1 -C5 alkyl group, or the like; Y... | 07/29/2003 |
| 6525056 | Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders Corticotropin releasing factor (CRF) antagonists of Formula (I): ##STR1## and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as wel... | 02/25/2003 |
| 6525060 | Triazolo(4,5-d)pyrimidine compounds Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. The compounds of the invention have the formula (I) as follows: ##STR1## wherein R, X and R1 through R3 ... | 02/25/2003 |
| 6506762 | Certain alkylene diamine-substituted heterocycles The present invention also provides a general method to whereby mono-, bi-, or tricyclic heterocycles may be modified to obtain potent antagonists at the NPY1 receptor. The present invention provides novel, potent, non-peptidic antagonists of N... | 01/14/2003 |
| 6462044 | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use The present invention describes novel nitrosated and/or nitrosylated phosphodiesterase inhibitors, and novel compositions containing at least one nitrosated and/or nitrosylated phosphodiesterase inhibitor, and, optionally, one or more compounds that donat... | 10/08/2002 |
| 6458950 | Compounds and pharmaceutical compositions containing the same A compound shown by the formula II, wherein Het is a mono- or polycyclic heterocyclic group comprising one or more hetero atoms selected from the group consisting of N, O and S which may be the same or different from each other; R1 is hydrogen,... | 10/01/2002 |
| 6458796 | Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one The present invention relates to novel dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one, to processes for their preparation and to their use as medicaments, in particular as inhibitors of cGMP-metabolizing phosphodiesterases.... | 10/01/2002 |
| 6455322 | Competition binding assay for detecting P2YADP receptor ligands The invention provides a competition binding assay for detecting P2YADP receptor ligands.... | 09/24/2002 |
| 6436945 | Substituted O6-benzyl-8-aza-guanines The present invention provides AGT inactivating compounds, for example, substituted O6 -benzyl-8-aza-guanines of the formula ##STR1## wherein R, for example, is pivaloyloxymethyl as well as pharmaceutical compositions comprising such compounds ... | 08/20/2002 |
| 6423716 | Nitrogenous heterocyclic compounds The present invention relates to nitrogen-containing heterocyclic compounds represented by formula (I): ##STR1## wherein W represents 1,4-piperazinediyl, etc.; U represents NR1 R2 (wherein R1 represents a hydrogen atom, a ... | 07/23/2002 |
| 6376667 | Solid phase synthesis of heterocycles Methods and compounds for the synthesis of heterocycles, including pyrimidine-2,4-diones, are disclosed. Also disclosed are solid supports useful for solid phase synthesis, and methods for making the solid supports.... | 04/23/2002 |
| 6369064 | Triazolo(4,5-d)pyrimidine compounds Triazolo[4,5-d]pyrimidine compounds are provided of the formula (I) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as defined in the specification. Compositions containing the compounds are also provided, together with proces... | 04/09/2002 |
| 6297232 | Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments The invention relates to triazolo[4,5-d]pyrimidin-3-yl derivatives which are useful in the treatment of platelet aggregation disorders.... | 10/02/2001 |
| 6251910 | 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists Compounds of formula having the following stereochemistry ##STR1## wherein R, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful as P2T receptor antagonists.... | 06/26/2001 |
| 6245769 | Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders Corticotropin releasing factor (CRF) antagonists of Formula (I): ##STR1## and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as wel... | 06/12/2001 |
| 6211179 | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses Disclosed are nitrosated and/or nitrosylated phosphodiesterase inhibitors having the formula NOn -PDE inhibitor where n is 1 or 2. The invention also provides compositions comprising such compounds in a pharmaceutically acceptable carrier. The ... | 04/03/2001 |
